Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2026-05-15 @ 9:05 PM
Study NCT ID:
NCT06990204
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-05-25
First Post:
2025-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia)
Sponsor:
Gedeon Richter Plc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EAEU-GCO-AZL-01-2024
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None